Design of an unmanned Martian polar exploration system

The design of an unmanned Martian polar exploration system is presented. The system elements include subsystems for transportation of material from earth to Mars, study of the Martian north pole, power generation, and communications. Early next century, three Atlas 2AS launch vehicles will be used to insert three Earth-Mars transfer vehicles, or buses, into a low-energy transfer orbit. Capture at Mars will be accomplished by aerobraking into a circular orbit. Each bus contains four landers and a communications satellite. Six of the twelve total landers will be deployed at 60 deg intervals along 80 deg N, and the remaining six landers at 5 deg intervals along 30 deg E from 65 deg N to 90 deg N by a combination of retrorockets and parachutes. The three communications satellites will be deployed at altitudes of 500 km in circular polar orbits that are 120 deg out of phase. These placements maximize the polar coverage of the science and communications subsystems. Each lander contains scientific equipment, two microrovers, power supplies, communications equipment, and a science computer. The lander scientific equipment includes a microweather station, seismometer, thermal probe, x-ray spectrometer, camera, and sounding rockets. One rover, designed for short-range (less than 2 km) excursions from the lander, includes a mass spectrometer for mineral analysis, an auger/borescope system for depth profiling, a deployable thermal probe, and charge coupled device cameras for terrain visualization/navigation. The second rover, designed for longer-range (2-5 km) excursions from the lander, includes radar sounding/mapping equipment, a seismometer, and laser ranging devices. Power for all subsystems is supplied by a combination of solar cells, Ni-H batteries, and radioisotope thermoelectric generators. Communications are sequenced from rovers, sounding rockets, and remote sensors to the lander, then to the satellites, through the Deep Space Network to and from earth

Leadership Networking: Connect, Collaborate, Create

Networking is essential to effective leadership in today's organizations. Leaders who are skilled networkers have access to people, information, and resources to help solve problems and create opportunities. Leaders who neglect their networks are missing out on a critical component of their role as leaders. This book will help leaders take a new view of networking and provide insight into how to enhance their networks and become effective at leadership networking

Differences in morning and evening fatigue in oncology patients and their family caregivers

PURPOSE OF THE RESEARCH: To identify distinct latent classes of individuals based on ratings of morning and evening fatigue; evaluate for differences in phenotypic characteristics, as well as symptom and quality of life scores, among these latent classes; and evaluate for an overlap in morning and evening fatigue class membership. PATIENTS AND METHODS: In a sample of 167 oncology outpatients and 85 of their FCs, growth mixture modeling was used to identify distinct latent classes based on ratings of morning and evening fatigue obtained before, during, and after radiation therapy. Analyses of variance and Chi Square analyses were used to evaluate for differences among the morning and evening fatigue latent classes. RESULTS: Three distinct latent classes for morning fatigue were identified. Participants in the High Morning Fatigue class (47%) were younger and had lower functional status. Three distinct latent classes for evening fatigue were identified. Participants in the High Evening Fatigue class (61%) were younger, more likely to be female, more likely to have children at home, and more likely to be a FC. Only 10.3% of participants were classified in both the Very Low Morning and Low Evening Fatigue classes and 41.3% were classified in both the High Morning and High Evening Fatigue classes. CONCLUSIONS: Different characteristics were associated with morning and evening fatigue, which suggests that morning and evening fatigue may be distinct but related symptoms. Additional research is needed to elucidate the mechanisms that may underlie diurnal variability in fatigue

The return of the Phoenix: the 1963 International Congress of Zoology and American zoologists in the twentieth century

This paper examines the International Congress of Zoology held in Washington D.C. in 1963 as a portrait of American zoologists’ search for effective and rewarding relationships with both each other and the public. Organizers of the congress envisioned the congress as a last ditch effort to unify the disparate subdisciplines of zoology, overcome the barriers of specialization, and ward off the heady claims of more reductionist biologists. The problems zoologists faced as they worked to fulfill these ambitious goals illuminate some of the challenges faced by members of the naturalist tradition as they worked to establish disciplinary unity while seeking public support in the competitive world of twentieth century science

Minireview: Epigenetic Changes in Ovarian Cancer

Epigenetic aberrations, including DNA methylation, histone modifications, and micro-RNA dysregulation, are now well established in the development and progression of ovarian cancer, and their gradual accumulation is associated with advancing disease stage and grade. Epigenetic aberrations are relatively stable, associated with distinct disease subtypes, and present in circulating serum, representing promising diagnostic, prognostic, and pharmacodynamic biomarkers. In contrast to DNA mutations and deletions, aberrant gene-repressive epigenetic modifications are potentially reversible by epigenetic therapies, including inhibitors of DNA methylation or histone-modifying enzymes. Although epigenetic monotherapies have not shown activity against solid tumors, including ovarian cancer, preclinical studies suggest they will be effective when used in combination with one another or with conventional chemotherapeutics, and combinatorial epigenetic therapy regiments are being examined in cancer clinical trials. A greater understanding of the role of epigenetics in ovarian neoplasia will provide for improved interventions against this devastating malignancy